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The Fas-activated serine/threonine kinase (FASTK) family of
proteins has recently emerged as a central regulator of mito-
chondrial gene expression through the function of an unusual
RNA-binding domain named RAP (for RNA-binding domain
abundant in Apicomplexans), shared by all six members of the
family. Here we describe the role of one of the less characterized
members, FASTKD3, in mitochondrial RNA metabolism. First,
we show that, in contrast to FASTK, FASTKD2, and FASTKD5,
FASTKD3doesnot localize inmitochondrialRNAgranules,which
are sites of processing and maturation of mtRNAs and ribosome
biogenesis. Second, we generated FASTKD3 homozygous knock-
out cell lines by homologous recombination and observed that the
absence of FASTKD3 resulted in increased steady-state levels and
half-lives of a subset ofmaturemitochondrialmRNAs:ND2,ND3,
CYTB, COX2, and ATP8/6. No aberrant processing of RNA pre-
cursorswasobserved.Rescueexperimentsdemonstrated thatRAP
domain is required for FASTKD3 function in mRNA stability.
Besides, we describe that FASTKD3 is required for efficient COX1
mRNAtranslationwithoutalteringmRNAlevels,whichresults ina
decrease in the steady-state levels of COX1protein. This finding is
associated with reduced mitochondrial complex IV assembly and
activity.Ourobservations suggest that the functionof this familyof
proteins goes beyond RNA processing and ribosome assembly
and includes RNA stability and translation regulation within
mitochondria.
Mitochondria are thought to be descendants of endosymbi-
otic bacteria. During its evolution into the current “power-
house” organelles of the eukaryotic cell, the endosymbiont
transferred many of its essential genes to the nuclear chromo-
somes. In humans, mtDNA is a circular 16.6 kb that encodes 2
rRNAs, 22 tRNAs, and 13 protein-coding genes. The genome is
transcribed into two long polycistronic heavy-strand and light-
strand transcripts reminiscent of bacterial operons. The two
rRNAs and most of the mRNAs are flanked by tRNAs. The
polycistronic nature of the transcripts and the flanking tRNAs
are the basis of the “tRNA punctuation” model. In this model,
RNase P and Z recognize the secondary structure of the tRNA
precursors and cleave the RNA, leading to the release of the
tRNAs and the mRNAs from the precursor RNA (1). The non-
canonical mRNAs do not have tRNAs flanking both ends. For
these mRNAs, which include ATP8/6, Cox3, Cox1, CYTB,
ND5, and ND6, the tRNA punctuation model is insufficient.
Little is known about the mechanisms by which the 5 and 3
ends of thesemRNAs are generated. Amember of the pentatri-
copeptide repeat (PPR)5 protein family, PTCD2, has been
reported to be involved in the processing of the pre-processed
ND5-CYTB transcript (2).
The identification and characterization of a novel family of
mitochondrial proteins named FASTK (Fas-activated serine/
threonine kinase) have shed new light on the mechanisms con-
trolling mitochondrial post-transcriptional RNA processing
and translation. This family is composed of six members:
FASTK, the founding member, and its homologs FASTKD1–5
(3). All members have been found only in vertebrates (3) and
were identified as RNA-binding proteins on the basis of
mRNA-bound proteome studies (4–6) and share three
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domains called FAST_1, FAST_2, and RAP (3). According to
homology predictions, the RAP (an acronym for RNA-binding
domain abundant in Apicomplexans) domain is a putative
RNA-binding domain (7), whereas the functions of FAST_1
and FAST_2 domains remain unknown.
FASTK and FASTKD2 were recently found to accumulate
into distinct foci that colocalize with newly synthesized mito-
chondrial RNA in mitochondrial RNA granules (MRGs) first
observed over a decade ago (8), and whose function has been
revealed recently (9). Different proteins have been found to
localize inMRGs, such as GRSF1, RNase P, andDDX28, among
other proteins (9–12). The biological properties of the proteins
present in MRGs suggest that these foci are sites of processing
and maturation of newly synthesized mtRNAs and ribosome
assembly. Interestingly, recent studies have shown that both
FASTK and FASTKD2 are required for the expression of the
ND6 mRNA, which is the only mRNA encoded on the light
strand, and has no tRNA at the 3 end (13, 14). Besides that, the
absence of FASTKD2 leads to aberrant processing and expres-
sion of 16S rRNA, which results in impaired mitochondrial
translation and oxidative phosphorylation assembly defects
(14, 15). It is important to note that Ghezzi et al. (16) found
homozygosity for a nonsensemutation in FASTKD2 in two sib-
lings with familial infantile mitochondrial encephalopathy, fur-
ther underlying the importance of FASTKD2 in mitochondrial
function. A recent study has shown that endogenous FASTKD5
partially colocalizes with MRGs (15), although our previous
observations with a tagged version of FASTKD5 do not support
this finding (3, 13). Despite conflicting data regarding the loca-
tion of FASTKD5 in MRGs, it has been unequivocally demon-
strated that FASTKD5 is essential for processing the three non-
canonical transcripts encoded on the heavy chain (15). As a
result of this property, FASTKD5 depletion renders COX1
mRNA almost undetectable, which severely reduces the syn-
thesis of COX1 protein, resulting in a complex IV defect (15).
FASTKD1, FASTKD3, and FASTKD4 (TBRG4) do not local-
ize in MRGs. FASTKD4 was found to modulate the half-lives
of a subset of mitochondrial mRNAs and to associate with
mtRNAs in vivo (17). Until now, little is known about the two
members FASTKD1 and FASTKD3. We have previously
reported that FASTKD3 is required for mitochondrial respira-
tion and interacts with components of the RNA metabolism
and translation machineries (3). In this study, we explore the
role of FASTKD3 in mitochondrial RNA metabolism and
translation.
Results
Generation of FASTKD3-deficient Cell Lines—All six FASTK
family members have been annotated as RNA-binding proteins
(RBPs) in independent mRNA-bound proteome studies (4–6).
More recently, the three family members, namely FASTK,
FASTKD2, and FASTKD5, have been reported to localize to
mitochondrial RNA granules, which are considered centers for
post-transcriptional RNA processing and ribosome biogenesis
(13, 15). However, no colocalization with BrU-labeled RNA
granules was observed for FASTKD1, FASTKD3, or FASTKD4
(13). Here we confirm that FASTKD3 does not concentrate in
endogenousmitochondrial RNAgranules stainedwith the anti-
FASTKD2 antibody (supplemental Fig. 1), suggesting that its
putative role in RNAmetabolismmay extend beyond these new
recently described foci.
We generated FASTKD3 knock-out U2OS cells to investi-
gate the importance of FASTKD3 in mitochondrial RNA
metabolism. The genomic FASTKD3 locus contains seven
exons. Exon 2 contains the first ATG and represents themajor-
ity of the coding region (78%). We constructed a targeting
vector designed to remove the entire exon 2, replacing it with
loxP-flanked blasticidin resistance cassette (Fig. 1A). We also
engineeredCRISPR/Cas9n against 20 nucleotides located at the
5 end of intron 2 to facilitate homologous recombination.
Puromycin-resistant colonies were checked for recombination
byPCR (Fig. 1B). The single targeted cells obtainedwere treated
with recombinant cell-permeant TAT-NLS-Cre recombinase
to delete loxP-flanked blasticidin resistance cassette. Resultant
cells were then subjected to a second round of gene targeting,
and biallelic knock-out cells were identified by PCR (Fig. 1B).
The absence of FASTKD3 in knock-out cells was confirmed by
Western blotting (Fig. 1C).
The Absence of FASTKD3 Leads to an Increase of the Steady-
state Levels and Half-lives of a Subset of mtRNAs—To explore
the role of FASTKD3 in mitochondrial RNA metabolism,
we first performed Northern blotting analysis to compare
the expression of mitochondrial RNAs in wild type and
FASTKD3/ cells. FASTKD3/ cells showed increased
steady-state levels ofmaturemRNAs for ND2 (1.97 0.14-fold
increase), ND3 (2.29 0.03-fold increase), CYTB (1.58 0.16-
fold increase), COX2 (1.85  0.19-fold increase), and ATP8/6
(1.64  0.11-fold increase) as compared with wild type cells
(Fig. 2, A and B). The steady-state levels of all other mtDNA-
encoded RNAs, including the other seven ORFs and the ribo-
somal RNAs 12S and 16S, were similar between wild type and
FASTKD3/ cells. As expected, FASTKD3/ cells showed
an intermediate phenotype. The increase in the steady-state
levels of ND2, ND3, CYTB, COX2, and ATP8/6 transcripts in
FASTKD3/ cells was confirmed by qRT-PCR, and the results
are shown in supplemental Table 1. No alterations in the pre-
cursor mRNA levels were observed in FASTKD3/ cells,
except for a 40% decrease in RNA15 precursor (encompassing
ATPase8/6-COX3 mRNA) and a nonsignificant decrease
RNA19 precursor (encompassing 16S rRNA-tRNALeu(UUA/G)-
ND1 mRNA).
Certain physiological circumstances, such as high energy
needs, stimulate mitochondrial biogenesis, which leads to an
increase inmitochondrial transcripts associated with increased
mtDNA replication and transcription (18). This mechanism
seemed unlikely to contribute to the mRNA phenotype found
in FASTKD3/ cells because that would lead to a global
increase of steady-state levels of mtRNAs. Moreover, we have
previously reported that siRNA-mediated FASTKD3 silencing
does not affect mtDNA content (3). Thus, our most plausible
hypothesis was that the increase in the steady-state levels
of ND2, ND3, CYTB, COX2, and ATP8/6 transcripts in
FASTKD3/ cells was due to an increase in their half-lives. To
measure the half-lives of the mitochondrial mRNAs, we
blocked mitochondrial transcription with ethidium bromide.
Cells were harvested at different times after the addition of the
FASTKD3 andMitochondrial RNAMetabolism
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inhibitor, and mitochondrial mRNA steady-state levels were
measured by qRT-PCR at each time point. The half-life of each
mRNAwas calculated as described previously (19). As shown in
Fig. 2C, ND2, ND3, CYTB, COX2, and ATP8/6 transcripts in
FASTKD3/ cells showed longer half-lives as compared with
those in control cells. As expected, the COX1 mRNA half-life
was unaltered in the absence of FASTKD3.
We next performed rescue experiments by stably expressing
full-length FASTKD3-FLAG-HA, a FASTKD3 mutant that
lacks the RAP domain (FASTKD3RAP-FLAG-HA), or a
FASTKD3mutant that lacks the last five amino acid residues of
the RAP domain (FASTKD3646–650) in FASTKD3/ cells.
FASTKD3646–650 mutant was generated on the basis of a
previous report showing that point mutations Y616A, L617A,
K618A, and K620A (NP_004740) at the C terminus end of
FASTKD4 RAP domain lead to loss of function of FASTKD4
(17). In Fig. 3A, we show the sequence alignment of the RAP
domain of all FASTK members and highlight the five partially
conserved amino acids at the C terminus.
As expected, overexpression of full-length FASTKD3-
FLAG-HA was able to rescue the FASTKD3/ phenotype
(Fig. 3B), reaching steady-state levels of ND2 and ND3 tran-
scripts similar to those seen in control wild type cells. Simi-
larly, the levels of the transcripts CYTB, COX2, and ATP8/6
were rescued to levels comparable with those in control cells.
As expected from our previous results, the levels of expres-
sion of ND5mRNAwere similar in all the cell lines. In agree-
ment with previous work suggesting that the RAP domain is
required for function of FASTK proteins (13, 17), expression
of FASTKD3RAP-FLAG-HA did not rescue the FASTKD3/
phenotype. Finally, expression of FASTKD3646–650-FLAG-
HA was also unable to rescue the mRNA levels for the altered
transcripts in FASTKD3/ cells. The three FLAG-HA recom-
binant proteins were expressed at similar levels as determined
by Western blotting (Fig. 3B). We also transiently expressed
GFP-tagged full-length FASTKD3, FASTKD3RAP, or
FASTKD3646–650 in U2OS cells and confirmed by confocal
microscopy that they are all located to mitochondria and
were expressed at similar levels (Fig. 3C). These results
ruled out the possibility that the inability of mutants
FASTKD3RAP or FASTKD3646–650 to rescue the
FASTKD3/ phenotype was simply due to altered expres-
sion or location within the cell.
The Absence of FASTKD3 Leads to a Selective Decrease in
COX1 Translation—We next explored the role of FASTKD3 in
mitochondrial translation. De novo protein synthesis was mea-
sured by metabolic labeling in the presence of emetine, which
inhibits cytosolic translation. As shown in Fig. 4A, increase in
the steady-state levels ofND2,ND3,CYTB,COX2, andATP8/6
transcripts did not lead to over-synthesis of the corresponding
proteins. Surprisingly, the absence of FASTKD3 caused a selec-
tive 40% reduction in the synthesis of COX1 (Fig. 4A). No
significant alterations were detected in the de novo synthesis of
other mitochondrial proteins in the FASTKD3/ cells. We
show representative experiments performed in two indepen-
dent FASTKD3/ clones.
We next explored the steady-state levels of COX1 in the
FASTKD3/ cells. As expected, FASTKD3/ showed
decreased protein levels of COX1 (2-fold reduction) as com-
pared with wild type cells (Fig. 4B). The steady-state levels
of other mtDNA-encoded (COX2) and nuclear encoded
(NDUFB8, NDUFA9, SDHB, UQCRC2, COX5A, and ATP5A)
A
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subunits of respiratory complexes were similar between
FASTKD3/ and wild type cells (Fig. 4B).
We next looked at the ability of full-length FASTKD3 and
FASTKD3mutantsRAP and646–650 to restore the steady-
state levels of COX1 protein. As described above, we used
FASTKD3/ cells stably expressing FLAG-HA-tagged full-
length and truncated versions of FASTKD3. Only the full-
length construct was able to rescue the steady-state levels of
COX1 protein in FASTKD3/ cells (Fig. 4C). Altogether, our
observations demonstrate that FASTKD3 has a dual function
affecting both mitochondrial mRNA stability and translation
and that both activities seem to require the RAP domain.
The Absence of FASTKD3 Results in Defective Complex IV
Assembly and Activity—The decrease in COX1 steady-state
levels by deleting FASTKD3 prompted us to investigate the
integrity of the respiratory supercomplexes (SC) by 1D Blue
Native-PAGE (BN-PAGE) using antibodies against NDUFA9
(complex I, CI), core 2 (complex III, CIII), andCOX5a (complex
IV, CIV) subunits that are reported to be incorporated in late
steps of complex assembly (20). Our results showed that free
CIV is reduced in FASTKD3/ cells. The CIII included in the
SC IIIIVwas strongly decreased in FASTKD3/ cells, which
in turn showed an accumulation of CIII in the SC IIII (Fig.
5A). However, there were no apparent changes in the SC
IIIIIV (the so-called respirasome).
Next, we measured the activity of the complexes of the res-
piratory chain in crude mitochondria isolated from FASTKD3
or the control wild type cell lines (Fig. 5B). All activities were
normalized to citrate synthase activity measured in the respec-
tive mitochondrial preparations. Consistent with a reduced
level of assembled CIV, COX activity in FASTKD3/ cells
showed a 33% decrease as comparedwith that of wild type cells.
Unexpectedly, we also observed that FASTKD3/ cells had a
mild but significant decrease in complex II activity. Our data
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FIGURE 2.Mitochondrial RNA analysis in FASTKD3/ cells. A, RNA isolated from the indicated cell lines was analyzed by Northern blotting hybridization
with probes specific for themitochondrial mRNAs and rRNAs, and as a loading control, with probes for 7SL (signal recognition particle RNA). A representative
experiment done in triplicates is shown. B, intensities of radioactive bands on Northern blots shown in A were quantified by densitometric analysis using
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Procedures.” The half-life of eachmitochondrial mRNAwas calculated using the formula t1⁄2	 ln2/, where  is the slope of mRNA decay. Data are expressed
as means S.D. (n	 5).
FASTKD3 andMitochondrial RNAMetabolism
25880 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 50•DECEMBER 9, 2016
 at U
N
IV
ERSID
A
D
 D
E V
A
LLA
D
O
LID
 on M
arch 13, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
demonstrate that FASTKD3 is required for a fully assembled
and active CIV.
Discussion
Here we report the role of FASTKD3 in the regulation of
mitochondrial gene expression. We show that targeted disrup-
tion of FASTKD3 gene leads to an increase in the half-lives and
steady-state levels of mature mitochondrial transcripts ND2,
ND3, CYTB, COX2, andATP8/6, and that this activity requires
the RAP domain of FASTKD3. In addition, we show that
FASTKD3 is necessary for the translation of COX1, but not for
the stability of its mRNA.
Previous work on other members of the FASTK family has
shed light on the function of this emerging family of proteins in
the regulation of mitochondrial RNAs. This includes the regu-
lation of RNA processing as well as the maturation and assem-
bly of the mitochondrial ribosomes (13–15, 17). Interestingly,
this is the first report that demonstrates that a FASTK family
member negatively regulates the stability of a subset of mito-
chondrial transcripts and selectively enhances translation.
These findings raise interesting questions about the mecha-
nism of action of FASTK proteins. FASTK has been reported to
bind to ND6 mRNA and prevent its 3 end degradation by the
mitochondrial degradosome, thus allowing correct ND6 pro-
cessing (13). This “barrier mechanism” is not expected to be
responsible for the phenotype found in FASTKD3/ cells
because the deletion of FASTKD3 leads to the accumulation of
mitochondrial mRNA rather than their depletion. However,
FASTKD3 might bind to target RNAs in a way similar to how
FASTK binds to ND6 and then degrade the target RNAs either
directly or indirectly through the recruitment of the degrada-
tion machinery. Likewise, the apparent precursor processing
defect reported for FASTKD5-depleted cells could be explained
by binding to the atypical ATP8/6-COX3 junction and subse-
quent cleavage by FASTKD5 or by proteins recruited by
FASTKD5 with nuclease activity. Therefore, it is likely that
FASTK proteins have different (even opposite)molecular func-
tions based on their ability to interact with RNA and would
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involve trans-acting factors such as the RNA degradation
machinery (as in the case of FASTK), among others still to be
defined. In this context, it is interesting to note that FASTKD2
has been recently identified in a 16S regulatory complex
together with three pseudouridine synthases that are essential
for 16S stability (21).
FASTK proteins share FAST_1, FAST_2, and RAP domains.
The RAP domain is particularly abundant in a phylum of para-
sitic protists known as apicomplexans, and it is thought to be an
RNA-binding domain (7). The exact biological importance of
the RAPdomain still needs to be clarified. For example, it seems
to be required for Raa3-mediated chloroplast group II intron
trans-splicing activity in Chlamydomonas reinhardtii (22).
Concerning its importance in the functions of FASTK proteins,
we have previously reported that the RAP domain is required
for the alternative splicing activity of nuclear FASTK (23).More
recently, Wolf et al. (17) have reported that four characteristic
RAP domain residues located at the end of the domain are
required for the ability of FASTKD4 to stabilize a subset of
mitochondrial transcripts. Also, Jourdain et al. (13) have
reported that the RAP domain is essential for the interaction of
FASTKwithND6mRNA.Here we report that the RAP domain
and also the final five residues of the domain are required for
FASTKD3 function inmRNA stability. Interestingly, homology
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modeling of the RAP domain of FASTKD2 revealed an endo-
nuclease-like fold that generates an interface rich in basic and
aromatic residues that might be involved in RNA binding (5).
The similarity between the RAP domain and endonucleases
was further highlighted by structural modeling by Boulouis et
al. (24). The conserved residues at the end of the RAP domain,
which are critical for the role of FASTKD2 and FASTKD5 in
mitochondrial mRNA stability, have not been identified as
important for catalysis in the endonucleases based on the align-
ments of these domains. Further biochemical and structural
studies will be required to determine whether the RAP domain
has endonuclease activity and the role of this domain in each
member of the FASTK family. As for FAST_1 and FAST_2
domains, their function remains unknown. Interestingly, Eber-
hard et al. (25) suggested that FAST_1 domain is structurally
related to octotricopeptide repeat (OPR) domains, which have
been proposed to structurally and functionally resemble PPR
domains. BothOPR and PPR domains are predicted to fold into
a pair of antiparallel -helices. Most OPR and PPR proteins are
predicted to be targeted to organelles where several have been
shown to control the post-transcriptional steps of gene expres-
sion such as RNA maturation, stability, and translation (24–
28). It will therefore be important to study the structure of
FAST_1 and FAST_2 domains and their contribution to the
function of FASTK proteins.
Interestingly, the translation rate of ND2, ND3, CYTB,
COX2, and ATP8/6 was not faster in FASTKD3/ cells
despite the increase in their mRNA levels. It has been previ-
ously demonstrated that mammalian mitochondria have a
great excess of transcripts under basal physiological conditions
(29). We speculate that the mitochondrial translation machin-
ery is saturated under basal physiological circumstances, and
therefore increases in transcript steady-state levels by 1.5–2-
fold are not accompanied by faster translation rates.
Importantly, we also describe that FASTKD3 is required for
efficient COX1 mRNA translation. Our data support a role
for FASTKD3 as a translational activator of mitochondrially
encoded COX1 because its absence causes a selective defect in
the translation of COX1 mRNA and decreased steady-state
protein levels without altering its mRNA levels. TACO1 has
been reported to selectively promote COX1mRNA translation
without altering mRNA levels in mammalian cells (30). Muta-
tions in TACO1 cause cytochrome c oxidase deficiency and
late-onset Leigh syndrome (30). The depletion of another
FASTK protein, FASTKD5, also leads to a selective COX1
translation defect; however, and in contrast to FASTKD3/
cells, depletion of FASTKD5 is accompanied by almost unde-
tectable levels of COX1 mature mRNA (15). The leucine-rich
pentatricopeptide repeat-containing (LRPPRC) protein has
been reported in in vitro studies to be necessary for the stability
and translation of the COX1 andCOX3 transcripts in themito-
chondria, and an amino acid substitution of this protein causes
the French-Canadian type of Leigh syndrome (LSFC) (31). We
have previously reported that LRPPRC takes part in a protein
complex with FASTKD3 (3), and we speculate that LRPPRC
and FASTKD3 could act cooperatively in the regulation of
COX1 translation. It will be important to unravel themolecular
mechanisms underlying the ability of FASTKD3 to promote
COX1 mRNA translation and to decipher the precise role that
the RAP domain plays in this function.
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Our data also demonstrate that FASTKD3 is required for a
fully assembled and active CIV. Our 1D BN-PAGE results
showed that in FASTKD3/ cells, the free CIV content is
decreased, which could be explained by the diminished COX1
protein steady-state levels.We also observed that the amount of
CIII taking part in the SC IIIIV was strongly decreased in
FASTKD3/ cells in which CIII seems to be incorporated into
the SC IIII. We can speculate that the low steady-state levels
of COX1 protein lead to both a drop in free complex IV and a
reorganization of SC IIIIV and SC IIII, with no apparent
changes in the respirasome (SC IIIIIV). An intense debate
exists concerning different models of supercomplexes biogen-
esis and assembly (32–35). However, CIV seems to be func-
tional both in free form and also when incorporated into super-
complexes (36), so the reduced levels of free CIV and SC IIIIV
could account for the decreased complex IV enzyme activity
seen in the FASTKD3/ cells. In vitro COX activity in
FASTKD3/ cells showed a 33% decrease as compared with
that of wild type cells. This finding correlates well with our
earlier observation that FASTKD3 depletion causes a decrease
in oxygen consumption (3). We have also observed that
FASTKD3/ cells have amild but significant decrease in com-
plex II activity. This result was unexpected because complex II
is exclusively nuclear encoded; however, native complex II con-
tent was similar to that of wild type cells, when an antibody
against subunit SDHC, which anchors other subunits of the
complex II to the internal mitochondrial membrane, was used
in BN-PAGE experiments. Further studies are required to
explain the differences between content and enzyme activity of
complex II.
In conclusion, we have established the consequences of a
genomic deletion of FASTKD3 in mitochondrial RNAmetabo-
lism, and our results demonstrate that FASTKD3has dual func-
tions: 1) as a modulator of the stability of a subset of mature
mitochondrial mRNAsND2, ND3, CYTB, COX2, and ATP8/6;
and 2) promoting COX1 mRNA translation. Our observations
suggest that the function of this emerging family of RNA-bind-
ing proteins goes beyondRNAprocessing and ribosome assem-
bly, and more detailed studies on FASTKD3 and the other
members will help us understand the interplay between them
and proteins relevant to post-transcriptional regulation of
mitochondrial gene expression.
Experimental Procedures
Cell Lines and Antibodies—The human osteosarcoma cell
lineU2OSwas obtained fromDr. Paul Anderson (HarvardUni-
versity). Rabbit polyclonal antibodies raised against the 350
C-terminal amino acids of human FASTKD3 and FASTKD2
were purchased from Proteintech (catalog numbers 18392-
1-AP and 17464-1-AP, respectively). Rabbit polyclonal anti-
body against actin was purchased from Sigma (catalog number
AC-40). Mouse monoclonal antibodies used were as follows:
anti-NDUFB8 (clone 20E9DH10C12), anti-SDHB (clone
21A11AE7), anti-UQCRC2 (clone 13G12AF12BB11), anti-
COX1 (clone 1D6E1A8), and anti-ATP5A (clone 15H4C4)
fromAbcam; anti-NDUFA9 (clone 20C11B11B11), anti-COX2
(clone 12C4F12), and anti-COX5A (clone 6E9B12D5) from
MitoSciences; anti-FLAG (cloneM2) from Sigma; and anti-HA
(clone 16B12) from Covance. All secondary fluorescent anti-
bodies were purchased fromMolecular Probes.
Fluorescence Microscopy—Briefly, FASTKD3-FLAG trans-
fected U2OS cells were fixed in 4% paraformaldehyde, and
immunostaining with anti-FLAG and anti-FASTKD2 antibod-
ies was performed in PBS containing 0.1%Triton X-100 and 3%
w/v BSA (Sigma-Aldrich). When indicated, EGFP-tagged full-
length FASTKD3 and FASTKD3 mutants RAP and 646–
650 plasmids were transfected into cells. EGFP plasmids were
generated by subcloning the respective cDNAs into the
pEGFP-N1 vector (Clontech). Mitochondria were stained with
100 nM MitoTracker Red CMXRos (Thermo Fisher Scientific),
and nuclei were stained with Hoechst 33258 (Sigma). Digital
images were captured using a Zeiss Axiophot microscope.
Generation of FASTKD3-deficient Cell Lines—The targeting
vector pAAV-MCS-FASTKD3was designed to delete exon 2 of
human FASTKD3, which encodes the initiator ATG, replacing
it with loxP-flanked blasticidin resistance cassette. pAAV-
MCS-FASTKD3 plasmid was obtained through the following
steps. First, the 5 homology arm (982-bp fragment) was ampli-
fied by PCR from U2OS genomic DNA using the primers 1F
(5-ATTGCGGCCGCCTGGAAAGCGCCTAGAAC-3, con-
taining a NotI site) and 1R (5-TAAGTCGACGCTCTATGC-
ATCTGAAAATCAGCGAGGTTAGAGCAAGGCAAG-3, con-
taining a SalI site, and a FASTKD3 exon 2 sequence artificially
introduced as a tool for screening). Second, a SalI/EcoRI frag-
ment (1,582 bp) containing a blasticidin resistance cassette
flanked by loxP sequences was obtained from a pBluescript II-
based plasmid previously generated in our laboratory. Third,
the 3 homology arm (1,380-bp fragment) was amplified by
PCR from U2OS genomic DNA using the primers 2F (5-
ATAGAATTCTAGAAAGCTGGAAAACGTGCCCTGAAG-
TTAACAGATGCTGG-3, containing an EcoRI site, and a
FASTKD3 exon 2 sequence artificially introduced as a tool for
screening) and 2R (5-TATGCGGCCGCATTTGGGCGTAG-
AAACTGA-3, containing a NotI site). The NotI/SalI-digested
5 homology arm, the SalI/EcoRI fragment containing a blasti-
cidin resistance cassette, and theEcoRI/NotI-digested3homo-
logy arm were cloned into the NotI site of pAAV-MCS (Add-
gene). We also engineered two CRISPR/Cas9n nickases,
targeting 20-nucleotide genomic sequences 5-GACCTGAA-
GTTAACAGATGC-3 and 5-TAGTGATCCGAAGATGA-
GAC-3, respectively, to facilitate homologous recombination.
Annealed oligonucleotides were cloned into the BbsI site of
pX335-U6-Chimeric_BB-CBh-hSpCas9n(D10A) containing
humanized Streptococcus pyogenes Cas9 (D10A) nickase (a gift
from Feng Zhang, Addgene plasmid number 42335) (37), and
the resulting plasmids were named as pX335-FASTKD3-
sgRNA#1 and pX335-FASTKD3-sgRNA#2, respectively. U2OS
cells were transfected with the targeting vector pAAV-
MCS-FASTKD3, pX335-FASTKD3-sgRNA#1, and pX335-
FASTKD3-sgRNA#2 using TransIT reagent (Mirus Bio).
Transfected cells were selected with 5 g/ml blasticidin, and
single colonies were checked for homologous recombination.
Homologous recombination at the 5 arm was verified by PCR
using primers P1F (5-CCCATGAAACACACATCCTG-3)
and P1R (5-GCTCTATGCATCTGAAAATCAG-3), and
expected fragment sizes were 1,777 bp for the wild type allele
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and 1,261 bp for the targeted allele. Homologous recombina-
tion at the 3 arm was verified by PCR using primers P2F (5-
TAGAAAGCTGGAAAACGTGC-3) and P2R (5-TTTGAT-
TAGTGAGTCTCATTCC-3), and expected fragment sizes
were 1,750 bp for the wild type allele and 1,450 bp for the tar-
geted allele. The single targeted cells obtainedwere treatedwith
recombinant cell-permeant TAT-NLS-Cre enzyme to delete
loxP-flanked blasticidin resistance cassette. Resultant cells
were then subjected to a second round of gene targeting with
pAAV-MCS-FASTKD3 vector as described above, to obtain
null mutant cells for FASTKD3 (FASTKD3/).
Rescue of FASTKD3/ Cells and Overexpression of
FASTKD3 Mutants—A full-length FASTKD3 human cDNA
(NM_024091) with C-terminal FLAG-HA tag was cloned into
the lentiviral vector pSin-EF2-Sox2-Pur digested with EcoRI
and SpeI. pSin-EF2-Sox2-Pur was a gift from James Thomson
(Addgene plasmid number 16577) (38). FASTKD3 mutants
RAP (deletion of amino acids 593–650) and646–650 (dele-
tion of amino acids 646–650) were created via QuikChange
Site-Directed mutagenesis (Agilent). Amino acid positions
refer to the National Center for Biotechnology Information
(NCBI) protein database accession number NP_076996. Lenti-
viral stocks were produced by transient cotransfection into the
human 293FT cell line (Thermo Fisher Scientific) with the
appropriate lentiviral expression plasmid and lentiviral helper
plasmids (psPAX2 packaging vector and pMD2.G envelope-
encoding vector) using Lipofectamine 2000. psPAX2 (Addgene
plasmid number 12260) and pMD2.G (Addgene plasmid num-
ber 12259) were gifts from Didier Trono. FASTKD3/ cells
were then transduced and selected with 2g/ml puromycin for
at least 2 weeks before assaying.
RNA Isolation, qRT-PCR, andNorthern Blotting—Total RNA
was extracted using TRIzol (Invitrogen). DNA contamination
from RNA samples was removed by treatment with DNase I
(Ambion). RNA (1 g) was reverse-transcribed using iScript
(Bio-Rad Laboratories) to generate cDNA that was quantified
by real-time PCR analysis (LightCycler 480 System; Roche Life
Science) using SYBR Green PCR Master Mix (Applied Biosys-
tems). The primers used for amplification were described in
detail by Nagao et al. (19).
Northern blotting was performed as in Jourdain et al. (11), in
which total RNA was extracted with TRI Reagent (Sigma-Al-
drich) and 5–15 g of RNA were separated on a denaturing
formaldehyde agarose gel and transferred via electrophoresis to
a nylonmembrane (GEHealthcare). Strand-specific [32P]UTP-
labeled riboprobes were transcribed using T7 polymerase (Bio-
Rad), and hybridization was performed at 60 °C in 50% form-
amide, 7% SDS, 0.2 M NaCl, 80 mM sodium phosphate (pH 7.4),
and 100 g/ml salmon sperm DNA. Imaging was done with a
phosphorimaging device (Bio-Rad). The RNA bands were
quantified by densitometric analysis using National Institutes
of Health ImageJ software.
Measurement of Mitochondrial mRNAs Half-lives—Mito-
chondrial transcription was disrupted with ethidium bromide
(0.5 g/ml). Cells were harvested at different time points after
the addition of the inhibitor (0, 30, 60, 90, 120, 150, 180, 240,
300, and 360 min), and mitochondrial mRNA steady-state lev-
els were measured by qRT-PCR as described above. The half-
life of each mitochondrial mRNA was calculated using the for-
mula t1⁄2	 ln2/, where  is the slope of mRNA decay (19).
Mitochondrial Translation Assay—Cells were grown to 70%
confluency inDMEMwith 10% FBS and thenwashed two times
with PBS. They were then incubated for 30 min with DMEM
without methionine and cysteine, supplemented with 10% dia-
lyzed FBS, GlutaMAX (Gibco), and 1 mM sodium pyruvate.
Cytoplasmic translation was inhibited by the addition of 100
g/ml emetine, and cells were incubated for 5 min. Finally,
translation products were labeled by the addition of 200 Ci of
[35S]cysteine and [35S]methionine (Easy Tag protein labeling
mix, PerkinElmer) for 1 h. Cells were washed three times with
PBS, harvested, and lysed. Proteins extracts were separated by
SDS-PAGE in a 12–20% linear gradient gel. The gel was stained
with Coomassie brilliant blue and dried, and radioactive bands
were visualized using a phosphorimaging device.
Respiratory Chain Activity—Respiratory activity of com-
plexes I, II, III, and IV was determined in a Shimadzu UV-1800
Spectrophotometer as described previously (39) with slight
modifications.
BN-PAGE—Mitochondrial pellets were isolated from wild
type andFASTKD3/ cells, andnativemitochondrial proteins
were prepared as described previously (33, 34). Native PAGE
Novex 3–12% Bis-Tris Protein Gels (Invitrogen) were loaded
with 30 g of mitochondrial protein. After electrophoresis,
proteins were transferred to nitrocellulose or PVDF mem-
branes at 1.3 A (constant) for 10 min and probed with specific
antibodies.
Statistics—All analyses were performed using Prism software
(GraphPad). Data are expressed as means  S.D. or means 
S.E. and were analyzed using one-way analysis of variance with
Bonferroni correction, the unpaired Student t test, or Mann-
WhitneyU test, as appropriate. *, p
 0.05, **, p
 0.01, ***, p

0.001.
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